we have the agm on the 17th Nov, 7 weeks away
David officially starts working next Tuesday as CEO.
at the agm we have directors needing to be re elected and performance shares to be be approved.
if we get no news in the mean time, I would suspect that any performance shares approval will be voted down and director re election maybe a bit iffy....
we also have the possibility of some sort of cr hovering around, maybe, maybe not.
what I do know from experience is when these things happen in a lot of companies, that any little detail of information is released to pump the share price. a pump of the sp before a cr, a pump before voting on performance shares.
but ADO has done the opposite. there is plenty of info that could have been released but hasn't???
we heard in the quarterly of the Alfred results overall sensitivity of 87.5% and 100% specificity. since then we have the full Alfred results
https://anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=12622000570785
with "
Arm B also showed higher sensitivity (100.00%) up to positive results with Ct 25 and 4-7 days post onset of symptoms,"
this is how tests are reported in many studies at the moment ct25 and 4-7 days onset of symptoms. its gold std. why hasn't this been shouted from the roof top???
what has happened in Romania for Eugeni being launched and available for sale. again no mention from anteotech
https://www.linkedin.com/posts/eyyu...tm_source=share&utm_medium=member_desktop
we are included in Burnett's institute's new Liver health test program. no mention
https://burnet.edu.au/news/1671_burnet_awarded_grant_to_develop_next_generation_liver_test
and I recently found we have filed a new patent a couple of weeks ago
http://pericles.ipaustralia.gov.au/ols/auspat/applicationDetails.do?applicationNo=2022902663
exactly the same invention title as a patent filed 7/3
http://pericles.ipaustralia.gov.au/ols/auspat/applicationDetails.do?applicationNo=2022900553
both titled "anode composition". from the annual report
"Intellectual Property
The ongoing protection of AnteoTech’s intellectual property (IP) in the Life Science and Energy divisions is key to securing the company’s long-term success. Through continuous product development and research by our two divisions, new approaches and applications of our surface management technology are evolving. This work has led to the filing of seven new provisional patent applications.
A provisional patent application has a life of 12 months, allowing AnteoTech to add undisclosed material to the application at any time during this period and make further determinations on filing for a standard patent."
they had 12 months to add to the 7/3 patent. they filed a completely new patent. why? have we developed an anode composition in addition to the silicon anode in our original patent ? why no mention?
this is what others and myself have discovered. there is most likely more.
a company that doesn't pump this sort of details in asx announcements or on social media or on their webpage newsroom, to me sounds like a company that is not concerned about the upcoming agm reception they will receive if no news is given and the chances of performance shares being approved ???
we have smart, very well experienced people on our board and management, who I am sure know shareholders feeling over the news blackout the last 6 months and the resulting sp slump.
so are ado confident they will announce something before the agm ? they certainly aren't in a rush to release info and pump the sp? I guess time will give the reasons why !!! GLTAH
(20min delay)